TCL Archive IDMC Recommends Halting Phase III Trial Of Onartuzumab in MET-Positive NSCLC March 28, 2014
TCL Archive Moyniham Bill Will Direct HHS to Exempt Centers Recognized By NCI From Prospective Payment System August 15, 1986